Genetic Transitions from CVC to Renaissance and Aurora

Deal News | May 22, 2025 | Legal Community Italy

Genetic Transitions from CVC to Renaissance and Aurora

Renaissance Partners, together with Aurora Growth Capital, has entered into a binding agreement to acquire the entire share capital of Genetic from CVC Strategic Opportunities. This transaction also sees the Pavese family, who are reinvesting in the new ownership structure alongside Renaissance and Aurora in a 50-50 partnership. Gatti Pavesi Bianchi Ludovici served as the legal advisors for Renaissance Partners and Aurora Growth Capital, coordinating with a multidisciplinary team, handling corporate, financing, and labor law aspects. On the fiscal and financial diligence front, Studio Riccardi Salom Tedeschi provided tax structuring advice, while STS Deloitte managed fiscal and financial due diligence. CVC, the selling party, was legally represented by PedersoliGattai, with facchini Rossi Michelutti Studio Legale Tributario offering fiscal advice, and Rothschild & Co acting as the financial advisor. The transaction underscores Genetic's role in the innovative therapeutic fields in Italy and Europe, targeting strategic international growth.

Sectors

  • Private Equity & Venture Capital
  • Legal Services
  • Biotechnology & Health

Geography

  • Italy – The companies and legal entities involved in the transaction are primarily based in Italy, and the article is sourced from an Italian news aggregator.
  • Europe – The transaction highlights the strategic growth ambitions of Genetic in the European markets.

Industry

  • Private Equity & Venture Capital – The article discusses the involvement of private equity firms Renaissance Partners and Aurora Growth Capital in the acquisition of Genetic.
  • Legal Services – Multiple law firms are involved in providing legal advisory services for the transaction, highlighting the role of legal services in M&A activities.
  • Biotechnology & Health – Genetic operates in the field of therapeutic innovation, which is part of the biotechnology and health sectors.

Financials

  • Not Disclosed – The specific financial terms of the transaction were not disclosed in the article.

Participants

NameRoleTypeDescription
GeneticTarget CompanyCompanyThe company being acquired by Renaissance Partners and Aurora Growth Capital.
CVC Strategic OpportunitiesSelling CompanyCompanyThe Private Equity firm selling Genetic.
Renaissance PartnersAcquiring CompanyCompanyOne of the acquiring entities forming a partnership with Aurora Growth Capital.
Aurora Growth CapitalAcquiring CompanyCompanyThe other acquiring entity in partnership with Renaissance Partners to acquire Genetic.
Pavese FamilyEquity PartnerPeopleReinvesting party maintaining a 50-50 partnership with Renaissance and Aurora.
Gatti Pavesi Bianchi LudoviciLegal AdvisorCompanyAdvisors for Renaissance Partners and Aurora Growth Capital.
PedersoliGattaiLegal AdvisorCompanyProvided legal advisory services for CVC Strategic Opportunities.
Facchini Rossi Michelutti Studio Legale TributarioLegal AdvisorCompanyProvided tax advisory for CVC.
Rothschild & CoFinancial AdvisorCompanyFinancial advisor for CVC and the Pavese family.
Studio Riccardi Salom TedeschiTax and Legal AdvisorCompanyProvided tax structuring advice for Aurora Growth Capital and Renaissance Partners.
STS DeloitteDue Diligence AdvisorCompanyHandled fiscal and financial due diligence.
Alma LEDLegal AdvisorCompanyAdvised the Pavese family in the transaction.
Mediobanca and BNP ParibasM&A AdvisorCompanyAssisted Aurora Growth Capital and Renaissance Partners in M&A matters.
Vitale e AssociatiFinancial AdvisorCompanyManaged the creation of the financing consortium.